ADIPOQ rs266729: What Your Genotype Means
The rs266729 variant is a common single nucleotide polymorphism located in the promoter region of the ADIPOQ gene. It is frequently studied for its potential influence on circulating adiponectin levels, metabolic health markers, and physical fitness outcomes.
What each genotype means
Typical adiponectin profile
This genotype is often considered the reference or baseline state for this variant. Research suggests that individuals with this genotype may maintain higher circulating adiponectin levels compared to those carrying the G allele, which is potentially beneficial for metabolic health. Associations with disease risk are inconsistent across different populations, so this result should be viewed as one small factor among many lifestyle and genetic influences.
This is the most common genotype observed in many studied populations, typically found in over half of the individuals sampled.
Intermediate adiponectin association
Carrying one copy of the G allele may be associated with slightly lower circulating adiponectin levels compared to the CC genotype. Some studies have linked the presence of the G allele to increased insulin resistance or metabolic risk, though these findings are mixed and often depend on specific population backgrounds or obesity status. You should focus on established healthy lifestyle habits, as the impact of this single variant is considered limited.
This heterozygous genotype is common, typically appearing in roughly one-third of individuals in many studied cohorts.
Potential metabolic risk marker
This genotype is associated with lower circulating adiponectin levels in several studies, which may correlate with higher insulin resistance or an increased risk for metabolic conditions in some populations. However, research results are conflicting, with some studies finding no significant association with disease risk, suggesting that environmental factors play a major role. If you have concerns about metabolic health or diabetes risk, please discuss these with your healthcare provider rather than relying on this genetic result alone.
This is the least common of the three genotypes, typically found in approximately 6% to 10% of individuals in studied populations.
Understanding the rs266729 Variant
The rs266729 variant is a single nucleotide polymorphism (SNP) situated in the promoter region of the ADIPOQ gene on chromosome 3q27. In this specific location, a cytosine (C) is replaced by a guanine (G). Because it resides in the promoter—a regulatory sequence that controls how much of a gene's product is made—researchers have long hypothesized that this variant may influence the expression levels of the ADIPOQ gene. Genetic variants in this region are often investigated to determine if they alter the body's ability to produce or regulate specific proteins. While the variant is well-documented in scientific literature, its functional impact can vary significantly depending on the population studied and the specific metabolic or fitness trait being measured.
The Role of the ADIPOQ Gene
The ADIPOQ gene provides instructions for producing a protein called adiponectin. This protein is a hormone secreted primarily by adipose (fat) tissue that plays a critical role in regulating glucose levels and fatty acid breakdown. Adiponectin is known for its insulin-sensitizing and anti-inflammatory properties, which help the body maintain metabolic balance. Because adiponectin levels are often lower in individuals with obesity or type 2 diabetes, researchers look at the ADIPOQ gene to understand the genetic underpinnings of these conditions. Variations in this gene, such as rs266729, are of interest because they may contribute to the natural variability in how much adiponectin an individual produces, potentially influencing their susceptibility to metabolic syndrome or their response to dietary and exercise interventions.
Research Associations and Evidence Strength
Evidence linking rs266729 to health outcomes is considered limited and often inconsistent across different populations. Some studies have associated the G allele with lower circulating adiponectin levels and an increased risk for metabolic conditions, while others have found no significant association. In the context of physical fitness, some research suggests that the GG genotype may be associated with lower scores in training-induced body changes, though these findings are not universal. Furthermore, studies on the variant's role in gestational hypertension and preeclampsia have yielded mixed results. Because these associations are often influenced by environmental factors, diet, and ethnicity, it is difficult to draw definitive conclusions. The scientific community continues to debate the extent to which this single variant contributes to complex traits, as many studies show conflicting results depending on the cohort's ancestry and lifestyle.
Population Frequency
The rs266729 variant is considered a common polymorphism across diverse human populations. Minor allele frequencies typically range between 5% and 21% depending on the specific ethnic group, making it a widely distributed genetic marker.
What This Information Means for You
It is important to understand that genetic variants like rs266729 do not determine your health destiny. While research explores how this variant might influence adiponectin levels or fitness responses, these associations are statistical in nature and do not provide a medical diagnosis. Many factors, including diet, physical activity, sleep, and overall lifestyle, play a much larger role in your metabolic health than any single SNP. You cannot use this information to predict your athletic performance or disease risk with certainty. If you are concerned about your metabolic health, cholesterol levels, or fitness goals, the most effective approach is to consult with a healthcare professional or a registered dietitian. They can provide personalized guidance based on your clinical history and current health status, rather than relying on individual genetic markers.
How common is this variant?
The rs266729 variant is common across global populations, with minor allele frequencies typically observed between 5% and 21%.
Frequently asked questions
Does the rs266729 genotype mean I will develop diabetes?
No. While some studies have explored links between this variant and metabolic traits, it is not a diagnostic tool for diabetes. Metabolic health is influenced by a complex combination of genetics, diet, and lifestyle factors.
Can I change my health outcomes if I have the GG genotype?
Yes. Genetic predispositions are not fixed outcomes. Lifestyle choices such as maintaining a balanced diet and regular physical activity are the primary drivers of metabolic health, regardless of your genotype.
Should I get tested for the ADIPOQ rs266729 variant?
There is no clinical recommendation to test for this variant. Because the evidence is limited and inconsistent, knowing your genotype for this SNP does not provide actionable medical information for most individuals.
Is rs266729 the same as other ADIPOQ variants?
No. The ADIPOQ gene has many different variants. Each SNP, such as rs266729, rs2241766, or rs1501299, is located in a different part of the gene and may have different effects on protein production.
Sources & further reading
Educational information only, last refreshed 10/31/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs266729?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ADIPOQ
Promoter variant (-11391G>A) in the ADIPOQ gene associated with circulating adiponectin levels.
Common regulatory polymorphism in the ADIPOQ gene associated with circulating adiponectin levels.
This SNP is associated with circulating adiponectin levels and metabolic syndrome risk.
This SNP is studied for its role in adiponectin levels and metabolic response to diet.
This SNP in the adiponectin gene is associated with insulin sensitivity and metabolic syndrome risk.
A candidate SNP in the adiponectin gene investigated for its potential association with human longevity and aging phenotypes.